Central Nervous System CancerTECAPNCT06485310
Interest of a TEteleconsultation of a Psychological Support Nurse on Psychological Distress in Patients With a Primary Malignancy of the Central Nervous System
A study testing Teleconsultation for psychological support in people with Central Nervous System Cancer and Psychological Distress, run by Centre Hospitalier Universitaire de la Réunion.
Trial summary
The goal of this clinal trial is to compare the effectiveness of nurse-led teleconsultation with usual care (intervention group) on psychological distress in patients with primary malignant tumors of the central nervous system between diagnosis and first anti-cancer treatment, versus usual care alone (control group). Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Central Nervous System Cancer, Psychological Distress
- What is being tested?
- Teleconsultation for psychological support
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 0 participants
- Where
- No sites listed yet
- Study dates
- 31 Mar 2026to 30 Jun 2028
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- aged 18 and over
- being treated for a primary malignant tumor of the central nervous system (positive biopsy)
- with a Mini-Mental State score greater than 24
- not receiving first-line treatment (chemotherapy, targeted radiotherapy, surgery)
- with a distress score above 3 on the Psychological Distress Thermometer
- have access to computer equipment equipped with a microphone and webcam (smartphone, computer)
Show all 9Show fewer
- able to read, write and speak French
- have given free and informed consent
- being affiliated to a social security scheme
Who cannot join
- with a history of psychiatric illness
- with recurrent cancer of the cerebral nervous system
- having begun first-line treatment (drug therapy, curative surgery, radiotherapy or palliative care)
- under guardianship, curatorship or deprived of liberty
About this study
Official title: Interest of a TEteleconsultation of a Psychological Support Nurse on Psychological Distress in Patients With a Primary Malignancy of the Central Nervous System Between the Announcement of the Diagnosis and the First Treatment
The goal of this clinal trial is to compare the effectiveness of nurse-led teleconsultation with usual care (intervention group) on psychological distress in patients with primary malignant tumors of the central nervous system between diagnosis and first anti-cancer treatment, versus usual care alone (control group).
Participants will be randomized into two groups :
Read more
- group A) intervention: usual care + nurse teleconsultation for psychological support
- group B) control: usual care alone
Enrolment = Day0 (D0)
Participants will :
- groups A and B: D0: complete 4 questionnaires (Quality of Life, Screening for Distress, Screening for Anxiety and Depression, Social Support Questionnaire)
- Group A : D0+2/4 das : nursing teleconsultation for psychological support
- Groups A and B: D0+10days : telephone call to complete the same 4 questionnaires as at inclusion
- Group A : D0+15days: semi-directive interview, at home, for voluntary patients.
Read the detailed description
The expected benefits are as follows:
For the patient :
- Reduction in pre-treatment psychological distress
- Reduced pre-treatment anxiety and depression
- Better understanding of disease and treatments
- Better adherence to the care proposed in the treatment pathway
- Reduced stress during first hospital treatment
For healthcare professionals :
- Early detection of psychological distress
- Early detection of unmet needs and appropriate individualized responses
- Establishment of a climate of trust between patient and caregiver
- Improved professional practices
For the healthcare system :
- Lower healthcare costs (fewer anxiolytic treatments, etc.)
- Therapy to be integrated into the treatment pathway of patients with central nervous system cancer
- Reduced socio-territorial inequalities in healthcare provision
- Being tested
- Teleconsultation for psychological support
- Medical subject headings
- Central Nervous System Neoplasms
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Teleconsultation for psychological supportOther
Teleconsultation with a nurse for psychological support, after the diagnosis has been announced, before hospitalization for the first treatment (chemotherapy, surgery, radiotherapy) in addition to the standard practice
| Study group | Role | What they receive |
|---|---|---|
| TELECONSULTATION | Experimental | Teleconsultation with a nurse for psychological support, after the diagnosis has been announced, before hospitalization for the first treatment (chemotherapy, surgery, radiotherapy) in addition to the standard practice. Receives: Other: Teleconsultation for psychological support |
| NO TELECONSULTATION | No intervention | The control group will be cared for according to standard practice (without teleconsultation) |
What is being measured
The primary outcome is the main question the study is designed to answer.
Distress thermometer
Comparison of the change in psychological distress score, measured using the psychological distress screening tool (from National Comprehensive Cancer Network) between the 2 groups between inclusion (T0) and before the first anti-cancer therapy (T1).
Measured: 10 days
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted3 Jul 2024
- Study start31 Mar 2026 (estimated)
- Primary completion31 Mar 2028 (estimated)
- Study completion30 Jun 2028 (estimated)
Why it stopped: The principal investigator has left the research center.
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Central Nervous System CancerStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Supportive care
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Enrolment
- 0 participants (actual)
Sponsor and investigators
- Lead sponsor
- Centre Hospitalier Universitaire de la Réunion
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06485310
- Sponsor's protocol ID
- 2024/CHU/02
- Acronym
- TECAP
- Status last verified
- Sep 2026
- First submitted
- 26 Jun 2024
- Last updated
- 23 Sep 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 23 Sep 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Interest of a TEteleconsultation of a Psychological Support Nurse on Psychological Distress in Patients With a Primary Malignancy of the Central Nervous System Between the Announcement of the Diagnosis and the First Treatment
- ClinicalTrials.gov ID
- NCT06485310
- Acronym / sponsor ID
- TECAP / 2024/CHU/02
- Study type
- Interventional
- Recruitment status
- WithdrawnReason stopped: The principal investigator has left the research center.
- Enrolment
- 0 participants (actual)
- Lead sponsor
- Centre Hospitalier Universitaire de la RéunionUniversity, hospital or other
- Study start
- 31 Mar 2026 (estimated)
- Primary completion
- 31 Mar 2028 (estimated)
- Study completion
- 30 Jun 2028 (estimated)
- First posted
- 3 Jul 2024 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The goal of this clinal trial is to compare the effectiveness of nurse-led teleconsultation with usual care (intervention group) on psychological distress in patients with primary malignant tumors of the central nervous system between diagnosis and first anti-cancer treatment, versus usual care alone (control group).
Participants will be randomized into two groups :
- group A) intervention: usual care + nurse teleconsultation for psychological support
- group B) control: usual care alone
Enrolment = Day0 (D0)
Participants will :
- groups A and B: D0: complete 4 questionnaires (Quality of Life, Screening for Distress, Screening for Anxiety and Depression, Social Support Questionnaire)
- Group A : D0+2/4 das : nursing teleconsultation for psychological support
- Groups A and B: D0+10days : telephone call to complete the same 4 questionnaires as at inclusion
- Group A : D0+15days: semi-directive interview, at home, for voluntary patients.
Detailed description
The expected benefits are as follows:
For the patient :
- Reduction in pre-treatment psychological distress
- Reduced pre-treatment anxiety and depression
- Better understanding of disease and treatments
- Better adherence to the care proposed in the treatment pathway
- Reduced stress during first hospital treatment
For healthcare professionals :
- Early detection of psychological distress
- Early detection of unmet needs and appropriate individualized responses
- Establishment of a climate of trust between patient and caregiver
- Improved professional practices
For the healthcare system :
- Lower healthcare costs (fewer anxiolytic treatments, etc.)
- Therapy to be integrated into the treatment pathway of patients with central nervous system cancer
- Reduced socio-territorial inequalities in healthcare provision
Study design
- Primary purpose
- Supportive care
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| TELECONSULTATION | Experimental | Other: Teleconsultation for psychological supportTeleconsultation with a nurse for psychological support, after the diagnosis has been announced, before hospitalization for the first treatment (chemotherapy, surgery, radiotherapy) in addition to the standard practice. |
| NO TELECONSULTATION | No intervention | –The control group will be cared for according to standard practice (without teleconsultation) |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (9 listed)
- aged 18 and over
- being treated for a primary malignant tumor of the central nervous system (positive biopsy)
- with a Mini-Mental State score greater than 24
- not receiving first-line treatment (chemotherapy, targeted radiotherapy, surgery)
- with a distress score above 3 on the Psychological Distress Thermometer
Key exclusion criteria (4 listed)
- with a history of psychiatric illness
- with recurrent cancer of the cerebral nervous system
- having begun first-line treatment (drug therapy, curative surgery, radiotherapy or palliative care)
- under guardianship, curatorship or deprived of liberty
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Teleconsultation for psychological supportTeleconsultation with a nurse for psychological support, after the diagnosis has been announced, before hospitalization for the first treatment (chemotherapy, surgery, radiotherapy) in addition to the standard practice | Other | TELECONSULTATION |
Primary outcome
Distress thermometer
Time frame: 10 days
Comparison of the change in psychological distress score, measured using the psychological distress screening tool (from National Comprehensive Cancer Network) between the 2 groups between inclusion (T0) and before the first anti-cancer therapy (T1).
Results and safety
The study was withdrawn before enrolling participants, so there are no results.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 23 Sep 2026.
- Individual participant dataSharing planned: No
Related trials for Central Nervous System Cancer
RecruitingPhase 2
Ibrutinib Combination Therapy in Transplant Ineligible Individuals With Newly Diagnosed Primary CNS Lymphoma
Non-hodgkin Lymphoma
RecruitingPhase 2
BrAin Metastasis in tripLe Negateive Breast Cancer: IvoneScimab and Trop2 ADC
Triple-Negative Breast Cancer (TNBC), Brain Metastases
Active, not recruiting
Effects of Whole-body Electrical Muscle Stimulation Exercise on Adults With Neuromuscular Disease
Neuromuscular Diseases (NMD), Amyotrophic Lateral Sclerosis
Active, not recruitingPhase 1
Prospective Exploratory Study of FAPi PET/CT With Histopathology Validation in Patients With Various Cancers
Bladder Carcinoma, Cervical Carcinoma
RecruitingPhase 1/2
PLX038 in Primary Central Nervous System Tumors Containing MYC or MYCN Amplifications
Glioma, Medulloblastoma
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
Questions about this trial
What is this clinical trial studying?
A study testing Teleconsultation for psychological support in people with Central Nervous System Cancer and Psychological Distress, run by Centre Hospitalier Universitaire de la Réunion.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 9 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: withdrawn, as of the sponsor's last update on 23 Sep 2026. Status can change between updates, so confirm with the study contact before making plans.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study was withdrawn before enrolling participants, so there are no results.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Distress thermometer (time frame: 10 days). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 23 Sep 2026.